Company Overview - Shanghai Congji Dental Clinic Co., Ltd. was established on July 5, 2023, in the Pudong New Area of Shanghai, with a registered capital of RMB 1 million [1] - The company is invested by Shanghai Tongce Dental Hospital Co., Ltd. and operates under the business scope of medical services [1] Financial Reporting Basis - The financial statements are prepared based on the going concern assumption and in accordance with the accounting standards issued by the Ministry of Finance [2] - The accounting records are maintained on an accrual basis, with historical cost as the measurement basis, except for certain financial instruments [2] Accounting Policies - The accounting period is divided into annual and interim periods, with the fiscal year running from January 1 to December 31 [2] - The company uses Renminbi as its functional currency for accounting purposes [2] Financial Assets and Liabilities - Financial assets are classified based on the business model for managing them and their cash flow characteristics, including those measured at amortized cost and at fair value [3][4] - Financial liabilities are classified into those measured at fair value with changes recognized in profit or loss and other financial liabilities [5][6] Impairment and Credit Losses - The company recognizes impairment losses for financial assets measured at amortized cost and those measured at fair value with changes recognized in other comprehensive income [10][11] - Expected credit losses are measured based on the credit risk of financial assets since initial recognition, with different methods applied depending on whether credit risk has significantly increased [12][13] Government Grants - Government grants are classified into those related to assets and those related to income, with specific accounting treatments for each type [18][19] - Grants related to assets are recognized as deferred income and amortized over the useful life of the related assets [21] Taxation - The corporate income tax rate is set at 20% on taxable income [25] - The company benefits from reduced tax rates for small and micro enterprises as per the relevant government policies [25]

证券简称：通策医疗 证券代码：600763 编号：临 2025-021 公司将取消监事会，免去监事张晓露先生、赵敏女士，原监事会的职权由董事会 审计委员会行使，同时废止《公司监事会议事规则》，并对《公司章程》中相关条款 做出相应修订。 在公司股东会审议通过取消监事会前，公司第十届监事会仍将严格按照《公司法》 《上市公司治理准则》等法律法规和规章制度的要求，勤勉尽责履行监督职能，维护 公司和全体股东利益。 表决结果：3 票同意；0 票弃权；0 票反对。 该议案需提请公司股东会审议。 具体内容详见公司同日在上海证券交易所网站（www.sse.com.cn）披露的《通 策医疗股份有限公司关于修订 <公司章程> 及其他制度的公告》。 通策医疗股份有限公司 第十届监事会第九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担个别及连带责任。 通策医疗股份有限公司（以下简称"本公司"、"公司"）第十届监事会第九次会 议于 2025 年 8 月 22 日在公司会议室召开，监事会会议通知及相关文件以书面通知、 电话确认的方式通知全体监事。本次 ...

Group 1 - The core viewpoint indicates that Tongce Medical has seen an increase in the number of shareholders, with a total of 88,100 shareholders as of June 30, 2025, representing a growth of 4,997 shareholders or 6.01% compared to the previous period [1] - The average number of shares held per shareholder decreased from 54,500 shares to 51,000 shares, while the average market value of shares held per shareholder fell from 216,800 yuan to 209,500 yuan [1] - During the same period, Tongce Medical's stock price increased by 13.28% [1] Group 2 - As of the latest report, Tongce Medical's stock price is 46.74 yuan, reflecting an increase of 0.95%, with a market capitalization of 20.906 billion yuan [2] - The changes in the number of shareholders and their average holdings over the last five reporting dates show a trend of increasing shareholder numbers but decreasing average holdings [3]

Core Viewpoint - Tongce Medical (600763.SH) reported a steady growth in its dental outpatient volume and financial performance for the first half of 2025, indicating resilience in the healthcare sector despite market challenges [1] Financial Performance - The total outpatient volume reached 1.7322 million visits, representing a year-on-year increase of 1.21% [1] - The company achieved a revenue of 1.448 billion yuan, reflecting a year-on-year growth of 2.68% [1] - The net profit attributable to shareholders was 321 million yuan, which is a year-on-year increase of 3.67% [1]

Core Viewpoint - Tongce Medical (600763.SH) announced the acquisition of 99% equity in Shanghai Cunjie Dental Clinic by its wholly-owned subsidiary Tongce Dental, with a total transaction amount of 46 million yuan [1] Group 1: Acquisition Details - The transaction involves Tongce Dental acquiring 99% of the equity, while Hangzhou Tongsong Medical Investment Management Co., Ltd. will acquire the remaining 1% [1] - The total transaction amount for the acquisition is 46 million yuan [1] Group 2: Strategic Implications - The target company is a wholly-owned subsidiary of Shanghai Tongce Dental Hospital Co., Ltd. [1] - The acquisition is classified as a related party transaction [1] - The company stated that this acquisition will enhance its brand presence and recognition in the high-end market, as well as optimize its business regional layout and product service structure [1]

Core Viewpoint - Tongce Medical (600763.SH) announced the acquisition of 99% equity in Shanghai Cunjie Dental Clinic by its wholly-owned subsidiary Tongce Dental, with a total transaction amount of 46 million yuan [1] Group 1: Acquisition Details - The acquisition involves Tongce Dental acquiring 99% of the equity, while Hangzhou Tongsong Medical Investment Management Co., Ltd. will acquire the remaining 1% [1] - The total transaction amount for the acquisition is 46 million yuan [1] Group 2: Strategic Implications - The target company is a wholly-owned subsidiary of Shanghai Tongce Dental Hospital Co., Ltd. [1] - The company stated that this acquisition will enhance its brand's influence and recognition in the high-end market, as well as optimize its business regional layout and product service structure [1]

证券简称：通策医疗 证券代码：600763 编号：临 2025-021 通策医疗股份有限公司 第十届监事会第九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担个别及连带责任。 通策医疗股份有限公司（以下简称"本公司"、"公司"）第十届监事会第九次会 议于 2025 年 8 月 22 日在公司会议室召开，监事会会议通知及相关文件以书面通知、 电话确认的方式通知全体监事。本次会议应出席监事 3 人，实际出席 3 人，会议由张 晓露先生主持，会议召集、召开程序符合《公司法》和《公司章程》的有关规定，合 法有效。 会议审议并通过以下议案： 1、审议通过《关于取消监事会免去监事的议案》 公司将取消监事会，免去监事张晓露先生、赵敏女士，原监事会的职权由董事会 审计委员会行使，同时废止《公司监事会议事规则》，并对《公司章程》中相关条款 做出相应修订。 在公司股东会审议通过取消监事会前，公司第十届监事会仍将严格按照《公司法》 《上市公司治理准则》等法律法规和规章制度的要求，勤勉尽责履行监督职能，维护 公司和全体股东利益。 表决结果：3 票 ...

第十届董事会第十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 证券简称：通策医疗 证券代码：600763 编号：临 2025-020 通策医疗股份有限公司 通策医疗股份有限公司（以下简称"公司"）第十届董事会第十次会议通知以电 子邮件、电话等方式发出，会议于 2025 年 8 月 22 日在浙江省杭州市西湖区西溪路双 口井巷 1 号通策医疗大厦 10 号楼会议室以现场结合通讯表决方式召开。 本次会议由公司董事长王毅女士主持。会议应出席董事 7 人，实际出席 7 人，公 司监事以及公司高管列席本次会议，会议的通知、召开符合《公司法》、《公司章程》 及有关法律法规规定，会议决议合法有效。 二、董事会会议审议情况 会议审议并通过以下议案： 1、审议通过《关于确认审计委员会成员及推选召集人的议案》 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上海证券交易 所股票上市规则（2025 年 4 月修订）》《上市公司章程指引（2025 年修订）》等相 关法律、法规、规范性文件的规定 ...

Core Viewpoint - Tongce Medical announced the acquisition of a 99% stake in Shanghai Cunjie Dental Clinic for a total transaction amount of 46 million yuan, constituting a related party transaction [1] Group 1 - The acquisition was made by Tongce Medical's wholly-owned subsidiary, Zhejiang Tongce Dental Hospital Investment Management Group Co., Ltd. [1] - The remaining 1% stake in the target company was acquired by another wholly-owned subsidiary, Hangzhou Tongsheng Medical Investment Management Co., Ltd. [1] - The target company is a wholly-owned subsidiary of Shanghai Tongce Dental Hospital Co., Ltd., with the actual controller being the legal representative, Lv Jianming [1]

上海存济口腔门诊部有限公司 审 计 报 告 众环审字(2025)0300656号 目 录 审计报告 | 财务报表 | | | --- | --- | | 资产负债表 | 1 | | 利润表 | 3 | | 现金流量表 | 4 | | 所有者权益变动表 | 5 | | 财务报表附注 | 7 | 起始页码 审计报告 众环审字(2025)0300656 号 上海存济口腔门诊部有限公司: 一、审计意见 我们审计了上海存济口腔门诊部有限公司(以下简称"存济口腔门诊部公司")财务报 表,包括 2024年 12月 31 日、2025年 4 月 30 日的资产负债表, 2024 年度、2025 年 1-4 月的利润表、现金流量表、所有者权益变动表以及相关财务报表附注。 我们认为,后附的财务报表在所有重大方面按照企业会计准则的规定编制,公允反映了 存济口腔门诊部公司 2024年 12 月 31 日、2025 年 4 月 30 日的财务状况以及 2024 年度、2025 年 1-4 月的经营成果和现金流量。 二、形成审计意见的基础 我们按照中国注册会计师审计准则的规定执行了审计工作。审计报告的"注册会计师对 财务报表审计的责任" ...